Ensayos clínicos

8.676 ensayos encontrados

CompletadoClinicalTrials.gov

Assessment of Food Environment and Physical Activity Opportunities in Three Neighbourhoods of Buenos Aires City

ObservacionalInicio: 1 de feb de 2011ID: NCT01388972

CompletadoFase 3ClinicalTrials.gov

A Phase III, Open-Label, Randomized Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Patients With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer Who Have Not Progressed After Concurrent Platinum-Based Chemoradiation

IntervencionalInicio: 24 de ago de 2020ID: NCT04513925

CompletadoFase 2ClinicalTrials.gov

A 24-week, Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Phase 2 Study of Different Doses of VX-509 in Adult Subjects With Active Rheumatoid Arthritis on Stable Methotrexate Therapy With 104-Week Open Label Extension

IntervencionalInicio: 1 de abr de 2012ID: NCT01590459

CompletadoFase 3ClinicalTrials.gov

A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 1

IntervencionalInicio: 1 de oct de 2013ID: NCT01957163

Activo, no reclutaFase 3ClinicalTrials.gov

CYCLONE 3: Estudio de fase 3, aleatorizado, doble ciego, controlado con placebo de abemaciclib en combinación con abiraterona más prednisona en hombres con cáncer de próstata metastásico con sensibilidad hormonal de alto riesgo

IntervencionalInicio: 14 de abr de 2022ID: NCT05288166

SuspendidoClinicalTrials.gov

Evaluation of a Drug Interactions Software (Interax-AI) in Outpatients.

IntervencionalInicio: 1 de ago de 2019ID: NCT03943524

CompletadoFase 3ClinicalTrials.gov

Phase 3 Trial to Investigate the Efficacy, Safety, and Tolerability of Blinatumomab as Consolidation Therapy Versus Conventional Consolidation Chemotherapy in Pediatric Subjects With HR First Relapse B-precursor ALL

IntervencionalInicio: 10 de nov de 2015ID: NCT02393859

CompletadoClinicalTrials.gov

Evaluación de la relación entre la inasistencia a turnos y la adherencia a las indicaciones médicas, en pacientes adultos con diabetes mellitus tipo 2, durante la pandemia de COVID-19: estudio transversal.

ObservacionalInicio: 1 de jul de 2020ID: NCT06501456

CompletadoFase 2ClinicalTrials.gov

The TEAM Trial (Tasigna Efficacy in Advanced Melanoma): A Phase II, Open Label, Multi-center, Single-arm Study to Assess the Efficacy of Tasigna ® in the Treatment of Patients With Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation

IntervencionalInicio: 1 de jun de 2010ID: NCT01028222

CompletadoFase 2ClinicalTrials.gov

A Phase II, Open-Label, Randomized, Multicenter Trial of Pazopanib (GW786034) in Combination With Lapatinib (GW572016) Compared to Pazopanib Monotherapy and Lapatinib Monotherapy in Subjects With FIGO Stage IVB or Recurrent or Persistent Cervical Cancer With Zero or One Prior Chemotherapy Regimen

IntervencionalInicio: 1 de nov de 2006ID: NCT00430781

ReclutandoClinicalTrials.gov

Estudio Observacional Prospectivo Multicéntrico Internacional para la Determinación de un Modelo de Índice Pronóstico Internacional de Linfoma Cutáneo y el Impacto de las Principales Terapias en Pacientes con Micosis Fungoide Avanzada y Síndrome de Sézary

ObservacionalInicio: 1 de oct de 2016ID: NCT02848274

ReclutandoFase 3ClinicalTrials.gov

Estudio global de fase III, aleatorizado, doble ciego, multicéntrico de rilvegostomig o pembrolizumab en monoterapia para el tratamiento de primera línea de pacientes con cáncer de pulmón de células no pequeñas metastásico con PD-L1 alto (ARTEMIDE-Lung04)

IntervencionalInicio: 10 de abr de 2025ID: NCT06868277

CompletadoFase 3ClinicalTrials.gov

A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)

IntervencionalInicio: 4 de dic de 2012ID: NCT01732822

ReclutandoFase 2ClinicalTrials.gov

Estudio de fase 2b, multicéntrico, aleatorizado, doble ciego, controlado con placebo de tratamiento con IMVT-1402 en participantes adultos con polineuropatía desmielinizante inflamatoria crónica (CIDP)

IntervencionalInicio: 18 de mar de 2025ID: NCT07032662

CompletadoFase 3ClinicalTrials.gov

A Randomized Placebo Controlled Study Of OSI-774 (TARCEVA) Plus Gemcitabine In Patients With Locally Advanced, Unresectable Or Metastatic Pancreatic Cancer

IntervencionalInicio: 29 de oct de 2001ID: NCT00026338

ReclutandoFase 3ClinicalTrials.gov

Estudio interventivo, aleatorizado, doble ciego, de grupos paralelos y controlado con placebo de Fase III para evaluar la eficacia y seguridad de eptinezumab IV en adolescentes (12-17 años) para el tratamiento preventivo de la migraña crónica

IntervencionalInicio: 30 de jun de 2021ID: NCT04965675

CompletadoFase 3ClinicalTrials.gov

A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)

IntervencionalInicio: 6 de mar de 2017ID: NCT03057977

CompletadoFase 3ClinicalTrials.gov

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes

IntervencionalInicio: 1 de nov de 2008ID: NCT00676338

RetiradoFase 2ClinicalTrials.gov

A Randomized, Active-Controlled, Open-Label, Phase 2 Clinical Trial of BMS-986213, in Combination With Various Standard-of-Care Therapeutic Regimens, in Participants With Recurrent, Locally Advanced, or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction (GEJ) Adenocarcinoma

IntervencionalInicio: 31 de oct de 2019ID: NCT03704077

CompletadoClinicalTrials.gov

Clitoral Sensitivity Enhancement With Hyperstacking of Er:YAG SMOOTH Mode

IntervencionalInicio: 1 de mar de 2022ID: NCT07152704